ERBB2 and breast cancer: As it is increasingly evident that the existing classifications of breast cancer subtypes often overlap and struggle to classify the heterogeneity of the disease [60], it may be naïve to expect that the function of α3β1 in breast cancer can only be predicted by the HER2 status.